Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)

PHASE2RecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 12, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2026

Conditions
Pancreatic Cancer
Interventions
RADIATION

Central-boost ablative dose delivered by stereotactic body radiation therapy

An inner and complete gross tumor volume (iGTV) is created within the gross tumor volume (GTV). For the liver or lung tumor, the convetional radiation dose is 35-45Gy/5f. Regarding the pancreatic tumor or retroperitoneal tumor, the radiation dose is 30-40Gy/5f. Hence, the radiation dose of iGTV should not be less than 120% of the dose of GTV.

Trial Locations (1)

200433

RECRUITING

Huojun Zhang, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER